31-45 of 1197

Off-Label Medicines in Fighting COVID-19 & Through the Years
COVID-19: On The FrontlinesOff-Label Medicines in Fighting COVID-19 & Through the Years

HHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
The Drug ReportHHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities

Drug Shortages During the COVID-19 Pandemic
The Drug ReportDrug Shortages During the COVID-19 Pandemic

Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
The Drug ReportNovel Therapeutic & Prevention Approaches to the Novel Coronavirus

Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
The Drug ReportUncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
- advertisement

A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP

REMS-Required Drug Monitoring During the COVID-19 Pandemic
The Drug ReportREMS-Required Drug Monitoring During the COVID-19 Pandemic

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
The Drug ReportRenin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19

CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
The Drug ReportCDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19

Update on Remdesivir, Investigational Antiviral for COVID-19
The Drug ReportUpdate on Remdesivir, Investigational Antiviral for COVID-19

A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
The Drug ReportA Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
- advertisement

A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs
The Drug ReportA New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs

Therapies & Vaccines on the Horizon for COVID-19
The Drug ReportTherapies & Vaccines on the Horizon for COVID-19

COVID-19 & the Economy: What Can We Expect?
Public Health On CallCOVID-19 & the Economy: What Can We Expect?






















